Company news

Nova Eye Medical Ltd news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Cleansing Notice

February 12, 2024

EYE Capital Raise for Expansion

February 12, 2024

USA Sales Update

January 8, 2024

Response to ASX Aware Query

January 3, 2024

USA Medicare Changes Withdrawn

December 28, 2023

Deferral of Proposed USA Medicare Changes

December 7, 2023

Further Update of Proposed USA Medicare Changes

November 27, 2023

AGM Presentation 23 November

November 22, 2023

Update on Proposed USA Medicare Changes

November 13, 2023

Proposed USA Medicare Changes

October 30, 2023

Pause in Trading

October 26, 2023

Investor Presentation 30 June 2023 Results

August 27, 2023

i Track Advance Sales in the USA

August 1, 2023

Nova Eye Medical Announces U.S. Market Clearance of the iTrack™ Advance Canaloplasty Device

April 12, 2023

FDA Clears iTrack Advance for US Launch

March 30, 2023

Notice Of General Meeting

March 28, 2023

Reinstatement to Quotation

March 1, 2023

Nova Eye Completes Placement

March 1, 2023

Half Year Accounts

February 28, 2023

Suspension from Official Quotation

February 28, 2023

Glaucoma Surgical Devices Sales Update

January 30, 2023

Status of MArket Clearance for iTrack Advance in the USA

December 11, 2022

AGM presentation 2022

November 17, 2022

Clarification Glaucoma Surgical Devices Sales Update

November 15, 2022

Results Announcement FY22

August 26, 2022

Investor Presentation FY22

August 26, 2022

Appendix 4E and Annual Report FY22

August 26, 2022

Glaucoma Sales update

July 7, 2022

iTrack Advance Commercial Roll-Out Commenced

June 7, 2022

AlphaRet Investor Presentation

May 2, 2022

2RT Pivotal Study and Regulatory Pathway

May 2, 2022

Nova Eye Medical Launches Next Generation Canaloplasty Device for Glaucoma, iTrack™ Advance

April 18, 2022

Investor presentation Half Year Results 31 December 2021

February 16, 2022

Half year results discussion

February 16, 2022

Glaucoma Sales Update

January 31, 2022

EYE AGM Presentation

November 24, 2021

US Government Stimulus Loan Forgiven

October 25, 2021

Aquisition of Glaucoma Patents

August 26, 2021

FY21 Appendix 4E and Annual Report

August 18, 2021

Full Year Results FY21

August 18, 2021

FY21 Investor presentation

August 18, 2021

FY21 Trading Update

July 20, 2021

First Patient enrolled in MAGIC Clinical Trial

April 29, 2021

2RT Post LEAD Review Shows Improved Treatment Benefits

March 4, 2021

Clinical trial to Assess Efficacy and Safety of i Track

March 1, 2021

Investor presentation Half year Results 31 December 2020

February 24, 2021

Half Year Results Discussion

February 24, 2021

Sales Update

November 25, 2020

Establishment of AlpaRET

October 25, 2020

FY20 Results presentation

August 30, 2020

← Newer news releases · Older news releases →

Calls

Decks

The 5 newest of 46 decks. Every deck is listed under its year.